LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization

[1]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[2]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[3]  Wei Zhang,et al.  Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response , 2018, Nature.

[4]  Hui Liu,et al.  Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma , 2018, Oncogene.

[5]  Bing Chen,et al.  exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes , 2017, Nucleic Acids Res..

[6]  Qihong Huang,et al.  Long non-coding RNAs in metastasis , 2017, Cancer and Metastasis Reviews.

[7]  Inhibition of breast cancer cell proliferation and tumorigenesis by long non-coding RNA RPPH1 down-regulation of miR-122 expression , 2017, Cancer Cell International.

[8]  W. Wagner,et al.  Tubulin beta 3 and 4 are involved in the generation of early fibrotic stages. , 2017, Cellular signalling.

[9]  H. Yao,et al.  Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation. , 2017, Cancer research.

[10]  M. Boutros,et al.  The lncRNA VELUCT strongly regulates viability of lung cancer cells despite its extremely low abundance , 2017, Nucleic acids research.

[11]  W. Ciszewski,et al.  β-III tubulin modulates the behavior of Snail overexpressed during the epithelial-to-mesenchymal transition in colon cancer cells. , 2016, Biochimica et biophysica acta.

[12]  Jin Ding,et al.  Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA. , 2016, Cancer cell.

[13]  M. Kretz,et al.  Non-coding RNAs: Classification, Biology and Functioning. , 2016, Advances in experimental medicine and biology.

[14]  M. Büchler,et al.  Combined evaluation of a panel of protein and miRNA serum‐exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity , 2015, International journal of cancer.

[15]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[16]  Lei Sun,et al.  HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer , 2015, Clinical & Experimental Metastasis.

[17]  M. Ferrer,et al.  Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium , 2015, Journal of extracellular vesicles.

[18]  William A. Flavahan,et al.  Periostin Secreted by Glioblastoma Stem Cells Recruits M2 Tumor-associated Macrophages and Promotes Malignant Growth , 2014, Nature Cell Biology.

[19]  Richard J Simpson,et al.  A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. , 2015, Methods in molecular biology.

[20]  T. Thamboo,et al.  Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression. , 2014, Immunity.

[21]  George A Calin,et al.  Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.

[22]  K. Flaherty,et al.  The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα. , 2014, Cancer discovery.

[23]  T. Xia,et al.  Long noncoding RNA associated-competing endogenous RNAs in gastric cancer , 2014, Scientific Reports.

[24]  George A Calin,et al.  Long noncoding RNA in prostate, bladder, and kidney cancer. , 2014, European urology.

[25]  F. Liu,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[26]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[27]  David R. Kelley,et al.  Topological organization of multichromosomal regions by the long intergenic noncoding RNA Firre , 2014, Nature Structural &Molecular Biology.

[28]  David R. Kelley,et al.  Topological Organization of Multi-chromosomal Regions by Firre , 2014, Nature structural & molecular biology.

[29]  J. Foekens,et al.  CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer , 2013, Genome research.

[30]  J. Segall,et al.  Wiskott-Aldrich syndrome protein regulates leukocyte-dependent breast cancer metastasis. , 2013, Cell reports.

[31]  T. Oda,et al.  Histological and prognostic importance of CD44+/CD24+/EpCAM+ expression in clinical pancreatic cancer , 2013, Cancer science.

[32]  Fangting Wu,et al.  LncRNA loc285194 is a p53-regulated tumor suppressor , 2013, Nucleic acids research.

[33]  C. Lewis,et al.  Macrophage regulation of tumor responses to anticancer therapies. , 2013, Cancer cell.

[34]  Howard Y. Chang,et al.  Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.

[35]  Cecilia Lässer,et al.  Toxoplasma gondii infection of fibroblasts causes the production of exosome-like vesicles containing a unique array of mRNA and miRNA transcripts compared to serum starvation , 2013, Journal of extracellular vesicles.

[36]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[37]  Fang Wang,et al.  The histone deacetylase 4/SP1/microrna‐200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma , 2011, Hepatology.

[38]  C. Théry.  Exosomes: secreted vesicles and intercellular communications , 2011, F1000 biology reports.

[39]  G. Sledge,et al.  Rethinking the metastatic cascade as a therapeutic target , 2011, Nature Reviews Clinical Oncology.

[40]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[41]  Howard Y. Chang,et al.  Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes , 2010, Science.

[42]  R. Letón,et al.  Tumoral and tissue‐specific expression of the major human β‐tubulin isotypes , 2010, Cytoskeleton.

[43]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[44]  George Poste,et al.  The "seed and soil" hypothesis revisited. , 2008, The Lancet. Oncology.

[45]  P. Allavena,et al.  The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. , 2008, Critical reviews in oncology/hematology.

[46]  G. Christofori.  New signals from the invasive front , 2006, Nature.

[47]  E. Martinelli,et al.  Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients , 2006, Clinical Cancer Research.

[48]  Heinz Bönisch,et al.  Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. , 2006, BioTechniques.

[49]  E. Martinelli,et al.  Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  C. Dumontet,et al.  Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non–Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy , 2005, Clinical Cancer Research.

[51]  C. Dumontet,et al.  Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[52]  J. Lieberman,et al.  Sustained Small Interfering RNA-Mediated HumanImmunodeficiency Virus Type 1 Inhibition in PrimaryMacrophages , 2003, Journal of Virology.

[53]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[54]  M. Kavallaris,et al.  Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol , 1999, British Journal of Cancer.

[55]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[56]  M. Bally,et al.  The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors. , 1997, The Journal of pharmacology and experimental therapeutics.

[57]  M. Baer,et al.  Structure and transcription of a human gene for H1 RNA, the RNA component of human RNase P , 1990, Nucleic Acids Res..

[58]  K. Sullivan,et al.  Molecular biology and genetics of tubulin. , 1985, Annual review of biochemistry.